THE INVOLVEMENT OF VITAMIN A [retinol (R)2 and its esters], which was identified
only many years later to be a precursor of retinoic acid (RA), in the process of formation of the tracheal and bronchopulmonary tree was described many years ago (1) . When weanling rats are fed a diet lacking R, the morphology of the trachea shows striking keratinized metaplasia, as shown in Fig. 1 The process of lung differentiation into alveoli occurs in the rat in the first 3 wk postnataily (8). Some time ago (19), rats were used to study the time-dependent expression of lung cellular R binding protein (CRBP) and cellular RA binding protein (CRABP) during perinatal development.
The quantitation of these proteins was performed using radiolabeled ligand by the sucrose gradient centrifugation method, which could not distinguish between the isoforms of these binding proteins discovered later. Striking changes in CRABP measured by the binding assay were observed.
CRABP levels rose soon after birth, peaked on day 10 postnatally (see Fig. 2 veoli (27) . In addition, the treatment of neonatal rats with RA prevents the action of dexamethasone given simultaneously. Thus, there is the possibility of using RA in patients with too few alveoli (27). Furthermore, these results show that dexamethasone can act antagonistically to the action of RA in the lungs. In adult lungs, dexamethasone inhibits the induction of expression of the gene for CRBP (28).
FETAL LUNG RETINYL ESTERS
At birth, the lung environment changes in a matter of seconds when this organ is suddently exposed to air and begins its function.
The metabolic alterations of retinyl esters in the lungs during this period are of interest.
It has been firmly established that fetal lungs accumulate retinyl esters (15, 29) ; therefore, the notion that the liver is the organ regulating R metabolism has to be modified. The question is, What is the function of these esters in lung development?
No later than day 17 of gestation, considerable amounts of retinyl esters are found in fetal rat lungs (29, 30) . When pregnant rats are given a single large dose of retinyl palmitate (50,000 I.U.) on day 16 of pregnancy, the levels of retinyl esters in fetal (days 17 through 21) and neonatal rat lungs (days 1 through 14) are considerably higher than in the offspring of control animals (31). The maternal administration of retinyl palmitate is also associated with an increase in the concentration of liver retinyl esters in the offspring, but this increase is smaller than the increase in the lungs. Thus, fetal lungs can take up retinyl esters or R from the mother and store them. Shortly before birth, the retinyl esters start to disappear from the lungs (15, 29). The amount of 9-cts-and all-trans-RA rises on day 19 of gestation and is even more elevated on day 2 postpartum (15 into epithelial and mesenchymal function, the effect of RA is seen only in the mesenchymal cells. These findings suggest that RA may not have a direct effect on epithelial cells, but may function indirectly through the mesenchyme (42). RA has been shown in various biological systems to affect the formation of quite a few growth factor receptors (36). For instance, RA can augment epidermal growth factor receptors. Thus, the differentiation of the epithelia may have its origins in the mesenchymal cells with the amplification of the response to the mitogen epidermal growth factor or other factors interacting with its receptors. A hypothesis has been put forward that mesenchymal epidermal growth factor produced by these cells acts as a paracrine factor mediating RA action in the process of epithelia formation (42). However, RA is not the only molecule that can induce branching of fetal lung. Acidic fibroblast growth factor was recently reported to affect branching of fetal lung rudiments explanted from mice on day 11 of gestation (43). The effect of this growth factor was observed in epithehum in the absence of mesenchyme.
Understandably, the morphologic process of branching is time dependent and very complex. Characterization of molecules and mechanisms involved in this phenomenon is another challenge for the future.
NUCLEAR

RETINOIC ACID RECEPTORS IN LUNG DEVELOPMENT
The essentiality of the RAR for fetal lung development was clearly demonstrated recently (44). Only double mutants of mice, not single mutants,
showed defects of the entire respiratory tract. The multiplicity of the RA receptors together with their apparent redundancy makes difficult the interpretation of alterations observed when expression of only some isoforms of these receptors is measured in fetal lungs. Indeed, changes in the mRNAs of RARa, 3, y in fetal and newborn rat lungs were observed (45). With respect to the abundant information available about nuclear RAR derived by the transfection assays, one important unanswered question remains: Do these receptors behave in the whole animal as they do in the transfection assays? With regard to the lungs, one example can be cited that this may be the case. Oral administration of RA to R-deficient rats activated the expression of the RAR gene, as in the transfection assay (46). In the developing lung, for example, the function of the heterodimers between the thyroid hormone receptor and RA receptor may be crucial to understanding the mechanism of action of multiple factors described to affect lung maturation when thyroid hormone is one of them (10). The consequences of RAR multiplicity and their redundance are discussed in the accompanying paper by Chambon (47) .
IMPACT ON CLINICAL STUDIES
Despite great research activity in basic science, as documented by an unprecedented rapid growth in the number of publications dealing with RA (11), the effect of the retinoid revolution on clinical research is relatively limited. In addition to the beneficial effects of high doses of retmy1 palmitate on xerophthalmia established in the distant past, newly gathered evidence has shown that intervention is accompanied by lowering the frequency of respiratory problems (48) .
Several reasons can be cited to explain why the introduction of retinoids as therapeutic agents has been sluggish. The main one may be that most clinicians were not instructed during their medical studies about the importance of natural retinoids in embryonic, fetal, and postnatal development.
A major concern in recent years has centered around the teratogenic effects of very high doses of 13-cis-RA, a rather successful therapeutic agent administered orally to cure humans suffering from hyperkeratoses of the skin (49 
